BioCentury
ARTICLE | Company News

MEDX, m-phasys GPCR antibody deal

November 12, 2001 8:00 AM UTC

Medarex (MEDX) and m-phasys (Tubingen, Germany) partnered to develop and market human antibodies against G protein-coupled receptors (GPCRs). The companies will use m-phasys' M-FOLD refolding technolo...